Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
939
NCT02628652
Study to Evaluate the Tolerability of Prebiotics on the Microbiota
Phase: N/A
Role: Lead Sponsor
Start: Oct 31, 2015
Completion: Dec 31, 2015
NCT02628678
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
Start: Nov 30, 2015
NCT04619875
A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects
Start: Sep 11, 2017
Completion: Nov 21, 2017
NCT04603378
A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects
Start: Sep 18, 2017
Completion: Nov 28, 2017
NCT03797131
Clinical Food Study to Evaluate the Effect of KB195 on Gut Nitrogen Metabolism in Patients With Urea Cycle Disorders
Start: Jan 6, 2019
Completion: Sep 1, 2019
NCT03855956
Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis
Start: Feb 27, 2019
Completion: Oct 1, 2019
NCT03944369
VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms
Start: Jun 27, 2019
Completion: Jun 16, 2020
NCT03933410
UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
Phase: Phase 2
Start: Sep 17, 2019
Completion: Mar 2, 2021
NCT04414124
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19
Start: Aug 2, 2020
Completion: Feb 2, 2021
NCT04508413
A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function
Start: Aug 12, 2020
Completion: Nov 29, 2021
NCT04486482
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function
Start: Jan 12, 2021
Completion: Mar 30, 2021
NCT04814914
"An Observational Clinical Study to Evaluate COVID-19 Symptoms in Long Hauler Patients Who Participated in K031-120 or K032-120"
Start: Mar 25, 2021
Completion: May 28, 2021